Ibex Medical Analytics is developing AI-driven algorithms in pathology, bringing a new promise to the fight against cancer, with a tremendous upside to patients and sizable savings to the healthcare system. The Ibex Second Read system for prostate cancer is now commercially available, while we develop solutions for additional applications and tissue types. It is the first AI-based application ever deployed in routine clinical use in a pathology lab, resulting in the first instance of cancer diagnosed by AI.